Arbutus Biopharma
ABUS
#6327
Rank
โ‚น53.77 B
Marketcap
โ‚น280.83
Share price
-1.50%
Change (1 day)
23.94%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -โ‚น5.87 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are โ‚น6.17 Million. , an increase over its 2023 earnings that were of -โ‚น6.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น5.97 Billion-4.02%
2023 -โ‚น6.22 Billion12.05%
2022 -โ‚น5.55 Billion-14.74%
2021 -โ‚น6.51 Billion19.61%
2020 -โ‚น5.45 Billion-61.69%
2019 -โ‚น14.21 Billion171.23%
2018 -โ‚น5.24 Billion-43.58%
2017 -โ‚น9.29 Billion-77.77%
2016 -โ‚น41.76 Billion532.77%
2015 -โ‚น6.6 Billion99.05%
2014 -โ‚น3.32 Billion175.82%
2013 -โ‚น1.21 Billion-143.7%
2012 โ‚น2.75 B-399.11%
2011 -โ‚น0.92 Billion-39.03%
2010 -โ‚น1.51 Billion100.55%
2009 -โ‚น0.76 Billion-28.56%
2008 -โ‚น1.06 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น3.01 B-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.19 Billion-96.91% Bahamas